| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/15/2007 | US20070037772 Pyrazolidinol compounds |
| 02/15/2007 | US20070037753 Dipeptide containing an imidazolidinedione or a pyrimidinedione group; inhibitors of the proteasome of cathepsins, especially cathepsin S, or of other proteases |
| 02/15/2007 | US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/15/2007 | CA2618888A1 Acyltryptophanols for fertility control |
| 02/15/2007 | CA2618586A1 Novel substituted 1,2,3-triazolylmethyl-benzothiophene or -indole and their use as leukotriene biosynthesis inhibitors |
| 02/15/2007 | CA2618524A1 Pyrazole derivatives having tyrosine kinase activity |
| 02/15/2007 | CA2618217A1 Marqueurs, leur procede de fabrication et leurs applications |
| 02/15/2007 | CA2617557A1 Benzimidazole derivatives as sirtuin modulators |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | CA2617289A1 Process for preparing an angiotensin ii receptor antagonist |
| 02/15/2007 | CA2616428A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
| 02/14/2007 | EP1751192A1 Cross-linked antibodies |
| 02/14/2007 | EP1751143A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 02/14/2007 | EP1751142A1 Pyrimidines derivatives for the treatment of abnormal cell growth |
| 02/14/2007 | EP1751141A1 Novel pyridazinone derivatives as inhibitors of cdk2 |
| 02/14/2007 | EP1751138A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
| 02/14/2007 | EP1751132A1 2-substituted pyrimidines and their use as pesticides |
| 02/14/2007 | EP1751131A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
| 02/14/2007 | EP1751124A2 Raf modulators and methods of use |
| 02/14/2007 | EP1751123A1 Process for preparing irbesartan |
| 02/14/2007 | EP1751119A1 Novel fused heterocycles and uses thereof |
| 02/14/2007 | EP1751118A1 Pyrimidines for use as plk inhibitors |
| 02/14/2007 | EP1751116A2 Pyrimidine compounds and use thereof |
| 02/14/2007 | EP1751104A1 Synthesis methods and intermediates for the manufacture of rizatriptan |
| 02/14/2007 | EP1750698A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
| 02/14/2007 | EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
| 02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 02/14/2007 | EP1259234B9 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 02/14/2007 | EP0999256B1 Compounds for organic el element and organic el element |
| 02/14/2007 | CN1914182A 喹唑啉衍生物 Quinazoline derivatives |
| 02/14/2007 | CN1914179A Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 02/14/2007 | CN1913900A Amino bustituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 02/14/2007 | CN1913898A Substituted piperazines |
| 02/14/2007 | CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 02/14/2007 | CN1300156C Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 02/14/2007 | CN1300138C Diheterocyclic compound, its preparing method and use |
| 02/14/2007 | CN1300116C 1H-indazole compound |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/13/2007 | US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine |
| 02/13/2007 | US7176320 Benzimidazole derivative |
| 02/13/2007 | US7176312 Kinase inhibitor scaffolds and methods for their preparation |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176227 Amine compounds and use thereof |
| 02/13/2007 | US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors |
| 02/13/2007 | US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity |
| 02/13/2007 | US7176211 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/13/2007 | US7176203 Imidazo-triazine derivatives as ligands for gaba receptors |
| 02/13/2007 | US7176201 Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/13/2007 | US7176200 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/13/2007 | US7176194 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
| 02/13/2007 | US7175958 Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same |
| 02/13/2007 | CA2463976C N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/13/2007 | CA2122236C Quinolines and their analogs |
| 02/08/2007 | WO2007016496A2 Dipiperazinyl ketones and related analogues |
| 02/08/2007 | WO2007016286A1 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine |
| 02/08/2007 | WO2007016261A2 Magnetic devices and methods for septal occlusion |
| 02/08/2007 | WO2007015064A1 Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders |
| 02/08/2007 | WO2007014924A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014923A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014922A1 Macrocyclic inhibitors of hepatitis c virus |
| 02/08/2007 | WO2007014412A1 Method for isolating 5-substituted tetrazoles |
| 02/08/2007 | WO2006113704A3 Subtituted heteroaryl cb1 antagonists |
| 02/08/2007 | US20070032655 Stable polymorph of flibanserin |
| 02/08/2007 | US20070032654 1-(2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl) ethyl)-2,3-dihydro-1H-benzimidazol-2-one (flibanserin); useful for treating psychological and nervous system disorders; prepared by heating a benzimidazolone compound with a piperazine derivative |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032651 Process for the preparation of carbostyril derivatives, such as aripiprazole and its intermediates |
| 02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/08/2007 | US20070032536 Compounds, compositions and methods |
| 02/08/2007 | US20070032530 Phenylpyridine derivatives |
| 02/08/2007 | US20070032529 Pyrazole compounds and their use as antidiabetes agents |
| 02/08/2007 | US20070032528 inhibitors of vascular endothelial growth factor receptor tyrosine kinase; antiproliferative agents; antitumor; 4-Hydroxy-3-(5-methylbenzimidazol-2-yl)hydropyridino[3,4-b]pyridin-2-one; nitrogen containing cyclic compounds |
| 02/08/2007 | US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 02/08/2007 | US20070032524 Diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 02/08/2007 | US20070032520 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 02/08/2007 | US20070032513 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide |
| 02/08/2007 | US20070032510 Antagonists to treat neurodegenerative diseases like Parkinson's disease; 2,4,6-trisubstituted pyrimidines; N-(2,6-diphenyl-pyrimidin-4-yl)-benzamide |
| 02/08/2007 | US20070032508 Quinazoline derivatives as tyrosine kinase inhibitors |
| 02/08/2007 | US20070032507 Treatment of diseases or disorders mediated by T lymphocytes and/or PKC; may be coadminstered with an immunosuppressant, immunomodulatory, anti-inflammatory, antiproliferative or anti-diabetic drug. |
| 02/08/2007 | US20070032506 Crystalline forms of (2r-trans)-6-chloro-5[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride |
| 02/08/2007 | US20070032505 Crystalline form of gatifloxacin |
| 02/08/2007 | US20070032504 Polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline |
| 02/08/2007 | US20070032502 Quinazoline derivatives useful in cancer treatment |
| 02/08/2007 | US20070032501 Aryl pyridines and methods of their use |
| 02/08/2007 | US20070032500 Therapeutic agents useful for treating pain |
| 02/08/2007 | US20070032497 Fused-ring compounds and use thereof as drugs |
| 02/08/2007 | US20070032494 Thyroid hormone analogs |
| 02/08/2007 | US20070032492 Cytokine Inhibitors |
| 02/08/2007 | US20070032484 Cathepsin K inhibitors |
| 02/08/2007 | US20070032478 Thiophene-2-carboxylic acid (4-{3-[(4-morpholin-4-yl-phenylamino)-methylene]-2-oxo-2,3-dihydro-1H-indole-6-carbonyl}-phenyl)-amide for modulating tyrosine kinase signal transduction to regulate, modulate and/or inhibit abnormal cell proliferation |
| 02/08/2007 | US20070032474 Use of a compound of formula 1 for making a pharmaceutical composition |